- Home
- KYMR vs TGI Comparison
KYMR vs TGI Comparison
Compare KYMR & TGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- TGI
- Stock Information
- Founded
- KYMR 2015
- TGI 1993
- Country
- KYMR United States
- TGI United States
- Employees
- KYMR N/A
- TGI N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- TGI Aerospace
- Sector
- KYMR Health Care
- TGI Industrials
- Exchange
- KYMR Nasdaq
- TGI Nasdaq
- Market Cap
- KYMR 1.8B
- TGI 2.0B
- IPO Year
- KYMR 2020
- TGI 1996
- Fundamental
- Price
- KYMR $45.87
- TGI $25.85
- Analyst Decision
- KYMR Strong Buy
- TGI Hold
- Analyst Count
- KYMR 16
- TGI 8
- Target Price
- KYMR $59.38
- TGI $20.63
- AVG Volume (30 Days)
- KYMR 1.1M
- TGI 1.5M
- Earning Date
- KYMR 08-06-2025
- TGI 08-06-2025
- Dividend Yield
- KYMR N/A
- TGI N/A
- EPS Growth
- KYMR N/A
- TGI N/A
- EPS
- KYMR N/A
- TGI 0.52
- Revenue
- KYMR $58,885,000.00
- TGI $1,261,962,000.00
- Revenue This Year
- KYMR $43.38
- TGI $9.20
- Revenue Next Year
- KYMR $10.97
- TGI $6.89
- P/E Ratio
- KYMR N/A
- TGI $49.18
- Revenue Growth
- KYMR N/A
- TGI 5.87
- 52 Week Low
- KYMR $19.45
- TGI $11.01
- 52 Week High
- KYMR $53.27
- TGI $25.96
- Technical
- Relative Strength Index (RSI)
- KYMR 67.58
- TGI 59.55
- Support Level
- KYMR $45.80
- TGI $25.70
- Resistance Level
- KYMR $47.51
- TGI $25.88
- Average True Range (ATR)
- KYMR 2.86
- TGI 0.08
- MACD
- KYMR -0.03
- TGI -0.02
- Stochastic Oscillator
- KYMR 67.19
- TGI 57.69
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.